医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Newly launched! 1st Personalised Medicine & Diagnostics Expo(IVD Japan 2014)

2013年09月12日 PM01:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

<img title="" src="" alt="Launched in response to huge demands from the industry! Asia's ONLY Exhibition & Conference specialised in Diagnostics and Testing for Personalised Medicine. 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014) www.ivdjapan.jp/en/ concurrently held with BIOtech 2014 Japan, Asia's largest bio event (Photo: Business Wire)” border=”0″ />Launched in response to huge demands from the industry! Asia’s ONLY Exhibition & Conference specialised in Diagnostics and Testing for Personalised Medicine. 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014) www.ivdjapan.jp/en/ concurrently held with BIOtech 2014 Japan, Asia’s largest bio event (Photo: Business Wire)

View and Share Photo

Close Window


TOKYO

Launched in response to huge demands from the industry! Asia’s ONLY Exhibition & Conference specialised in Diagnostics and Testing for Personalised Medicine.

Launched in response to huge demands from the industry! Asia's ONLY Exhibition & Conference speciali ...

Launched in response to huge demands from the industry! Asia’s ONLY Exhibition & Conference specialised in Diagnostics and Testing for Personalised Medicine. 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014) www.ivdjapan.jp/en/ concurrently held with BIOtech 2014 Japan, Asia’s largest bio event < May 14-16, 2014 at Tokyo Big Sight, Japan > (Photo: Business Wire)

1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014) www.ivdjapan.jp/en/
concurrently held with BIOtech 2014 Japan, Asia’s largest bio event
< May 14-16, 2014 at Tokyo Big Sight, Japan >

Reason of Launching / Japanese Market Situation
The Japanese Government is targeting Medical Care as the core of Japan’s growth strategy, and within that strategy, “Personalised Medicine” is chosen as one of the priority areas. A good example of that is the organisation of “Japanese NIH” with launching/preparation budget of approximately USD 2.26 billion, where 2 areas are chosen as priority sectors – Personalised Medicine and Regenerative Medicine. A series of new projects, easing of regulations and a large volume of subsidies involved, many overseas suppliers are setting their target to Japan and especially to these two fields.
Reflecting the market situation, Reed Exhibitions Japan Ltd., the organiser of Asia’s largest bio event (BIOtech 2014 Japan -13th Int’l Bio Technology Exhibition & Conference) has decided to launch “1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014)” concurrently with BIOtech Japan. Featuring the hottest fields in the current Japanese medical industry – Personalised Medicine and Regenerative Medicine (=covered by BIOtech Japan), these 2 shows will surely gather huge attention and are expected to attract 650 exhibitors and 15,000 visitors from around the world.

Event Outline

1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014) www.ivdjapan.jp/en/

(Asia’s ONLY Exhibition & Conference specialised in Diagnostics and Testing for Personalised Medicine)
Dates: May 14[Wed]-16[Fri], 2014
Venue: Tokyo Big Sight, Japan
Organised by: Reed Exhibitions Japan Ltd.
Concurrent Events: Conference/Academic Forum
 

Exhibit Profile

Equipment, Reagents, Contract Services, IT, etc. for Diagnostics and Testing for Personalised Medicine
 

Visitor Profile

-Lab Technicians/Technologists, Research Coordinators, Lab Personnel in Clinical Trial Centers, SMOs, CROs
-Lab Technicians/Technologists, Research Coordinators, Lab Personnel, Doctors in Medical Institutions
-Clinical/-related Researchers in Universities, National/Public Research Institutes
-Researchers specialized in Drug Discovery, Clinical Research in Pharmaceutical Companies
 

Concurrent Show:

BIOtech 2014 Japan – 13th Int’l Bio Technology Exhibition & Conference www.bio-t.jp/en/

Asia’s LARGEST bio event covering fields such as pharmaceutical research, drug discovery,
biopharmaceutical development, regenerative medicine, etc.
 

Concurrent Events
It is the concurrent events (Conference, Academic Forum) that make the event more attractive.
Last time, BIOtech 2013 Japan Conference included presentations on Personalised Medicine spoken by key industry leaders from F. Hoffmann-La Roche, Aichi Cancer Center Hospital and the Ministry of Health, Labour and Welfare. This year, more presentations on Personalised Medicine will join the Conference including Keynote Session inviting high-profile speakers.
(Other topics addressed at BIOtech 2013 Japan Conference: iPS Cell, Regenerative Medicine, Immunity, Antibody Drug, Computer Aided Drug Design, Drug Design/Discovery, and many others >>Program [2013])

Another co-held event is “Academic Forum”, where researchers from universities and research institutes present their latest research achievements. Unveiling the cutting-edge platform technologies and seeds by Japanese researchers and generating partnering opportunities, it will be another hot venue for business development/licensing professionals and investors.

Why not exhibit at IVD Japan 2014 and tap into the attractive market, Japan?
For exhibiting and other enquiries, please feel free to contact Show Management.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130911006479/en/

CONTACT

IVD Japan / BIOtech Japan Show Management,
Reed Exhibitions Japan
Ltd.
Kyoko Nagakusa (Ms.), +81-3-3349-8518
International PR
Email:
ivdjapan@reedexpo.co.jp
Website:
www.ivdjapan.jp/en/

同じカテゴリーの記事 

  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
  • Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China